Status: Recruiting
Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck
To determine the effect of neoadjuvant atezolizumab alone or in combination with other immune modulating agents on T-cell infiltration in advanced SCCHN. To determine the impact of neo-adjuvant immunotherapy on surgical outcomes.
Participants needed: 55
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Alain AlgaziUpdated: Jan 28, 2025Locations: 1
Eligibility criteria
Patients must have clinically suspected SCCHN that is amenable to surgical resec... [+20]
Is currently participating and receiving study therapy or has participated in a... [+38]